Archive · 19 Aug 2025
Healthcare Sector Sees More Deals Amid High Valuations
Healthcare companies are making more deals, like buying other companies.
This is happening because more people are getting sick with things like diabetes, and there are more older people needing care.
In India, people have more money and insurance, so they can afford better healthcare.
Companies want to grow, and buying others helps them do that quickly.
Even though the prices to buy these companies are high, they are still attractive because healthcare is expected to keep growing.
Indian companies are also leading these deals to get bigger and better in the market.
Healthcare, particularly in India, is seeing increased deal activity and consolidation.
Factors driving this include rising non-communicable diseases, an aging population, and higher disposable incomes.
High fragmentation in the market, especially in pharma and healthcare services, fuels acquisitions.
Valuations in India's healthcare sector remain high due to long-term growth potential.
Indian companies are increasingly active in healthcare deals, both in B2C and B2B segments.
- Who
- Rothschild & Co, healthcare companies.
- What
- Increased deal activity and consolidation in the healthcare sector.
- When
- Recent years, particularly post-COVID.
- Where
- India, with a global perspective.
- Why
- Driven by rising demand, market fragmentation, and strategic growth objectives.
High Valuations
Market Potential
Valuations
High Valuations
High valuations in healthcare could hinder deal closures.
Market Potential
High valuations are justified due to the long-term growth potential of the sector.
- Advisory Firm
- Rothschild & Co
- Deals Advised Annually
- 40 to 60
- Healthcare Sector Focus
- Services, hospitals, pharma, med-tech
- Valuations
- Punchy
- Market Trend
- Consolidation